Content area
Full Text
An adult woman developed bladder cancer during treatment with cyclophosphamide for skin disease and interstitial lung disease. Subsequently, she developed progression of systemic sclerosis-associated interstitial lung disease during treatment with BCG for bladder cancer.
The woman, who had a diffuse cutaneous systemic sclerosis presented with aggravating dyspnea at the age of 61 years. In 2003, she was diagnosed with diffuse cutaneous systemic sclerosis with severe skin disease, which was further complicated by interstitial lung disease. From October 2005 to July...